Cargando…
Should patient enrollment criteria for anti‐VEGF phase III trials be reconsidered
Autores principales: | Hanhart, Joel, Jeon, Sohee, Tuuminen, Raimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590675/ https://www.ncbi.nlm.nih.gov/pubmed/37731062 http://dx.doi.org/10.1111/1753-0407.13468 |
Ejemplares similares
-
Should we reconsider platelet content criteria for single donor platelets in West Bengal, India?
por: Javed, Rizwan, et al.
Publicado: (2017) -
Should Hepatitis B Serosurveys Methodology Be Reconsidered?
Publicado: (2010) -
A call to reconsider the new diagnostic criteria for gestational diabetes mellitus
por: Bell, Katy J.L., et al.
Publicado: (2023) -
Statin medication in patients with epiretinal membrane is associated with low intravitreal EPO, TGF-beta-1, and VEGF levels
por: Tuuminen, Raimo, et al.
Publicado: (2016) -
Reconsidering the Standard of Care for Peripheral Nerve Reconstruction
por: Safa, Bauback, et al.
Publicado: (2023)